Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Damora Therapeutics, Inc.(DMRA) | 0 | 8,713,000 | +8,713,000 | $0 | $225.67M | 16.30% | +$225.67M |
| Dianthus Therapeutics, Inc.(DNTH) | 2,137,191 | 2,537,191 | +400,000 | $88.07M | $212.92M | 15.38% | +$124.85M |
| Cogent Biosciences, Inc.(COGT) | 9,003,418 | 5,503,418 | -3,500,000 | $319.80M | $211.83M | 15.30% | -$107.97M |
| Spyre Therapeutics, Inc.(SYRE) | 4,018,101 | 4,018,101 | 0 | $131.63M | $202.67M | 14.64% | +$71.04M |
| Oruka Therapeutics, Inc.(ORKA) | 3,705,262 | 3,705,262 | 0 | $112.31M | $181.74M | 13.13% | +$69.44M |
| Viridian Therapeutics, Inc.(VRDN) | 3,914,458 | 3,914,458 | 0 | $121.82M | $76.57M | 5.53% | -$45.25M |
| Enliven Therapeutics Inc | 3,711,444 | 1,855,644 | -1,855,800 | $57.16M | $72.74M | 5.25% | +$15.59M |
| Jade Biosciences Inc | 4,553,494 | 4,553,494 | 0 | $70.26M | $63.98M | 4.62% | -$6.28M |
| Crescent Biopharma, Inc.(CBIO) | 2,747,866 | 2,747,866 | 0 | $32.59M | $50.48M | 3.65% | +$17.89M |
| Zenas BioPharma, Inc.(ZBIO) | 2,209,025 | 2,359,025 | +150,000 | $80.21M | $46.12M | 3.33% | -$34.09M |
| Apogee Therapeutics Inc | 2,048,647 | 298,647 | -1,750,000 | $154.63M | $25.14M | 1.82% | -$129.49M |
| Inhibikase Therapeutics, Inc.(IKT) | 8,625,000 | 8,625,000 | 0 | $17.68M | $14.49M | 1.05% | -$3.19M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 1,319,688 | 0 | -1,319,688 | $54.44M | $0 | — | -$54.44M |
| Nuvalent Inc | 727,563 | 0 | -727,563 | $73.19M | $0 | — | -$73.19M |